Latest news with #RM19.2m
Yahoo
31-05-2025
- Business
- Yahoo
Cnergenz Berhad First Quarter 2025 Earnings: EPS: RM0.001 (vs RM0.006 in 1Q 2024)
Revenue: RM19.2m (down 39% from 1Q 2024). Net income: RM422.0k (down 85% from 1Q 2024). Profit margin: 2.2% (down from 9.0% in 1Q 2024). The decrease in margin was driven by lower revenue. EPS: RM0.001 (down from RM0.006 in 1Q 2024). AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early. All figures shown in the chart above are for the trailing 12 month (TTM) period Cnergenz Berhad shares are down 16% from a week ago. Be aware that Cnergenz Berhad is showing 5 warning signs in our investment analysis and 2 of those make us uncomfortable... Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Yahoo
31-05-2025
- Business
- Yahoo
Cnergenz Berhad First Quarter 2025 Earnings: EPS: RM0.001 (vs RM0.006 in 1Q 2024)
Revenue: RM19.2m (down 39% from 1Q 2024). Net income: RM422.0k (down 85% from 1Q 2024). Profit margin: 2.2% (down from 9.0% in 1Q 2024). The decrease in margin was driven by lower revenue. EPS: RM0.001 (down from RM0.006 in 1Q 2024). AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early. All figures shown in the chart above are for the trailing 12 month (TTM) period Cnergenz Berhad shares are down 16% from a week ago. Be aware that Cnergenz Berhad is showing 5 warning signs in our investment analysis and 2 of those make us uncomfortable... Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Yahoo
29-05-2025
- Business
- Yahoo
MKH Oil Palm (East Kalimantan) Berhad Second Quarter 2025 Earnings: EPS: RM0.019 (vs RM0.027 in 2Q 2024)
Revenue: RM96.2m (up 6.2% from 2Q 2024). Net income: RM19.2m (down 8.5% from 2Q 2024). Profit margin: 20% (down from 23% in 2Q 2024). The decrease in margin was driven by higher expenses. EPS: RM0.019 (down from RM0.027 in 2Q 2024). AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early. All figures shown in the chart above are for the trailing 12 month (TTM) period MKH Oil Palm (East Kalimantan) Berhad's share price is broadly unchanged from a week ago. While it's very important to consider the profit and loss statement, you can also learn a lot about a company by looking at its balance sheet. We have a graphic representation of MKH Oil Palm (East Kalimantan) Berhad's balance sheet and an in-depth analysis of the company's financial position. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
03-03-2025
- Business
- Yahoo
G3 Global Berhad Full Year 2024 Earnings: RM0.005 loss per share (vs RM0.001 profit in FY 2023)
Revenue: RM58.8m (down 21% from FY 2023). Net loss: RM19.2m (down from RM1.89m profit in FY 2023). RM0.005 loss per share (down from RM0.001 profit in FY 2023). All figures shown in the chart above are for the trailing 12 month (TTM) period G3 Global Berhad shares are down 25% from a week ago. We should say that we've discovered 2 warning signs for G3 Global Berhad (1 is a bit unpleasant!) that you should be aware of before investing here. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
